101 related articles for article (PubMed ID: 15183842)
1. Functional analysis of the interleukin-5 receptor antagonist peptide, AF18748.
Rosas M; Uings IJ; van Aalst C; Lammers JW; Koenderman L; Coffer PJ
Cytokine; 2004 Jun; 26(6):247-54. PubMed ID: 15183842
[TBL] [Abstract][Full Text] [Related]
2. Modified peptide antagonists of interleukin 5 exhibit extended in vivo persistence but restricted species specificity.
Uings IJ; Balasubramanian P; McLoughlin PG; Yin Q; Dash L; Beresford A; Kearney S; Barrett RW; McKinnon M; England BP
Cytokine; 2001 Jul; 15(1):10-9. PubMed ID: 11509004
[TBL] [Abstract][Full Text] [Related]
3. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains.
England BP; Balasubramanian P; Uings I; Bethell S; Chen MJ; Schatz PJ; Yin Q; Chen YF; Whitehorn EA; Tsavaler A; Martens CL; Barrett RW; McKinnon M
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6862-7. PubMed ID: 10823900
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor.
Monahan J; Siegel N; Keith R; Caparon M; Christine L; Compton R; Cusik S; Hirsch J; Huynh M; Devine C; Polazzi J; Rangwala S; Tsai B; Portanova J
J Immunol; 1997 Oct; 159(8):4024-34. PubMed ID: 9378992
[TBL] [Abstract][Full Text] [Related]
5. Effect of a novel interleukin-5 receptor antagonist, YM-90709, on antigen-induced eosinophil infiltration into the airway of BDF1 mice.
Morokata T; Suzuki K; Ida K; Yamada T
Immunol Lett; 2005 Apr; 98(1):161-5. PubMed ID: 15790522
[TBL] [Abstract][Full Text] [Related]
6. [Genetic engineering of cytokine system on the tuberculosis research].
Takatsu K
Kekkaku; 1991 Sep; 66(9):629-34. PubMed ID: 1942734
[TBL] [Abstract][Full Text] [Related]
7. [Interleukin-5].
Yamaguchi Y
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1287-93. PubMed ID: 8031174
[TBL] [Abstract][Full Text] [Related]
8. Cytokine recognition by human interleukin 5 receptor.
Ishino T; Robertson N; Chaiken I
Vitam Horm; 2005; 71():321-44. PubMed ID: 16112273
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 5 in the link between the innate and acquired immune response.
Takatsu K; Kouro T; Nagai Y
Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
[TBL] [Abstract][Full Text] [Related]
10. Purification of soluble murine interleukin 5 (IL-5) receptor alpha expressed in Chinese hamster ovary cells and its action as an IL-5 antagonist.
Tsuruoka N; Yamashiro K; Tsujimoto M
Arch Biochem Biophys; 1993 Nov; 307(1):133-7. PubMed ID: 8239650
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the murine IL-5 receptor complex with the use of a panel of monoclonal antibodies. Relationship to the murine IL-3 receptor.
Van der Heyden J; Devos R; Plaetinck G; Fache I; Fiers W; Tavernier J
J Immunol; 1991 Nov; 147(10):3413-8. PubMed ID: 1940345
[TBL] [Abstract][Full Text] [Related]
12. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
Krause S; Behrends J; Borowski A; Lohrmann J; Lang S; Myrtek D; Lorenzen T; Virchow JC; Luttmann W; Friedrich K
Mol Immunol; 2006 Apr; 43(11):1799-807. PubMed ID: 16364441
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo inhibition of interleukin (IL)-5-mediated eosinopoiesis by murine IL-5Ralpha antisense oligonucleotide.
Lach-Trifilieff E; McKay RA; Monia BP; Karras JG; Walker C
Am J Respir Cell Mol Biol; 2001 Feb; 24(2):116-22. PubMed ID: 11159044
[TBL] [Abstract][Full Text] [Related]
14. Expression and in vitro properties of guinea pig IL-5: comparison to human and murine orthologs.
Scott CW; Budzilowicz C; Hubbs SJ; Stein M; Sobotka-Briner C; Wilkins DE
Mediators Inflamm; 2000; 9(3-4):181-7. PubMed ID: 11132776
[TBL] [Abstract][Full Text] [Related]
15. IL-5 and IL-5 receptor expression on human eosinophils in relation to eosinophil activation.
Chihara J; Capron M; Nakajima S
Biotechnol Ther; 1993; 4(3-4):271-83. PubMed ID: 8292975
[No Abstract] [Full Text] [Related]
16. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
[TBL] [Abstract][Full Text] [Related]
17. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
18. IL-5 and eosinophilia.
Takatsu K; Nakajima H
Curr Opin Immunol; 2008 Jun; 20(3):288-94. PubMed ID: 18511250
[TBL] [Abstract][Full Text] [Related]
19. Differential signalling for enhanced hexose uptake by interleukin (IL)-3 and IL-5 in male germ cells.
Rauch MC; Brito M; Zambrano A; Espinoza M; Pérez M; Yañez A; Rivas CI; Slebe JC; Vera JC; Concha II
Biochem J; 2004 Jul; 381(Pt 2):495-501. PubMed ID: 15018615
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-5 receptors on human lung eosinophils after segmental allergen challenge.
Julius P; Hochheim D; Böser K; Schmidt S; Myrtek D; Bachert C; Luttmann W; Virchow JC
Clin Exp Allergy; 2004 Jul; 34(7):1064-70. PubMed ID: 15248851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
